The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | Podnos Yale | Chief Medical Officer | Option exercise(M) | 5K | $2.00 | $11K |
| Jul 14, 2026 | Podnos Yale | Chief Medical Officer | Option exercise(M) | 18K | $1.87 | $34K |
| Jul 14, 2026 | Podnos Yale | Chief Medical Officer | Sell(S) | 5K | $6.35 | $35K |
| Jul 14, 2026 | Podnos Yale | Chief Medical Officer | Option exercise(M) | 5K | $2.00 | $11K |
| Jul 14, 2026 | Podnos Yale | Chief Medical Officer | Sell(S) | 18K | $6.43 | $116K |
| Jul 14, 2026 | Podnos Yale | Chief Medical Officer | Option exercise(M) | 18K | $1.87 | $34K |
| Jul 10, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 15K | $5.85 | $88K |
| Jul 7, 2026 | Stolper Mark | Director | Grant(A) | 26K | — | $0 |
| Jul 7, 2026 | Tzoumakas Kimberly Jo | Director | Grant(A) | 17K | — | $0 |
| Jun 23, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 18K | $5.02 | $90K |
| Jun 8, 2026 | Podnos Yale | Chief Medical Officer | Sell(S) | 23K | $5.38 | $126K |
| Jun 4, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 12K | $4.75 | $57K |
| May 21, 2026 | Podnos Yale | Chief Medical Officer | Other(J) | 2K | $4.47 | $8K |
| May 21, 2026 | Carter Robert Ross | Chief Financial Officer | Other(J) | 2K | $4.47 | $7K |
| May 21, 2026 | Virnich Daniel | Chief Executive Officer | Other(J) | 23K | $4.47 | $103K |
| May 20, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 34K | $4.07 | $136K |
| May 19, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 30K | $4.09 | $123K |
| May 19, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 5K | $4.05 | $20K |
| Apr 16, 2026 | Kaushal Mohit | Director | Sell(S) | 38K | $3.50 | $135K |
| Apr 14, 2026 | Kaushal Mohit | Director | Sell(S) | 57K | $3.50 | $201K |
| Apr 9, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 20K | $3.10 | $62K |
| Mar 27, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 27K | $2.96 | $81K |
| Mar 27, 2026 | Langsam Jeffrey | Chief Clinical Officer | Grant(A) | 70K | — | $0 |
| Mar 27, 2026 | Carter Robert Ross | Chief Financial Officer | Grant(A) | 203K | — | $0 |
| Mar 27, 2026 | Carter Robert Ross | Chief Financial Officer | Other(J) | 20K | $3.07 | $62K |
| Mar 27, 2026 | England Kristin | Chief Administrative Officer | Grant(A) | 56K | — | $0 |
| Mar 27, 2026 | Podnos Yale | Chief Medical Officer | Grant(A) | 66K | — | $0 |
| Mar 27, 2026 | Podnos Yale | Chief Medical Officer | Other(J) | 16K | $3.07 | $50K |
| Mar 27, 2026 | Virnich Daniel | Chief Executive Officer | Grant(A) | 671K | — | $0 |
| Mar 27, 2026 | Virnich Daniel | Chief Executive Officer | Other(J) | 99K | $3.07 | $302K |
| Mar 26, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 50K | $3.15 | $158K |
| Mar 24, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 125K | $3.11 | $389K |
| Mar 20, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 25K | $3.35 | $84K |
| Mar 17, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 75K | $3.42 | $257K |
| Mar 17, 2026 | Podnos Yale | Chief Medical Officer | Other(J) | 3K | $3.59 | $12K |
| Mar 17, 2026 | Carter Robert Ross | Chief Financial Officer | Other(J) | 1K | $3.59 | $5K |
| Mar 17, 2026 | Virnich Daniel | Chief Executive Officer | Other(J) | 12K | $3.59 | $42K |
| Mar 16, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 61K | $3.29 | $201K |
| Mar 13, 2026 | Chernett Jorey | 10% Owner | Buy(P) | 263K | $2.92 | $768K |
| Jan 2, 2026 | Carter Robert Ross | Chief Financial Officer | Other(J) | 244 | $3.67 | $895 |
| Dec 15, 2025 | Hively Brad | Director | Sell(S) | 13K | $3.77 | $50K |
| Nov 20, 2025 | Hively Brad | Director | Grant(A) | 32K | — | $0 |
| Nov 20, 2025 | Hively Brad | Director | Grant(A) | 42K | — | $0 |
| Nov 20, 2025 | Pacala Mark L | Director | Grant(A) | 35K | — | $0 |
| Nov 20, 2025 | Pacala Mark L | Director | Grant(A) | 46K | — | $0 |
| Nov 20, 2025 | Johnson Karen Marie | Director | Grant(A) | 37K | — | $0 |
| Nov 20, 2025 | Johnson Karen Marie | Director | Grant(A) | 48K | — | $0 |
| Nov 20, 2025 | Ling Gabriel | Director | Grant(A) | 37K | — | $0 |
| Nov 20, 2025 | Ling Gabriel | Director | Grant(A) | 46K | — | $0 |
| Nov 20, 2025 | Kaushal Mohit | Director | Grant(A) | 40K | — | $0 |
| Nov 20, 2025 | Kaushal Mohit | Director | Grant(A) | 51K | — | $0 |
| Nov 20, 2025 | McGeorge Anne | Director | Grant(A) | 68K | — | $0 |
| Nov 20, 2025 | McGeorge Anne | Director | Grant(A) | 40K | — | $0 |
| Nov 18, 2025 | Pacala Mark L | Director | Sell(S) | 47K | $4.00 | $187K |
| Nov 18, 2025 | Pacala Mark L | Director | Sell(S) | 2K | $4.00 | $9K |
| Nov 18, 2025 | Pacala Mark L | Director | Sell(S) | 1K | $4.00 | $5K |
| Nov 18, 2025 | Toi M, LLC | Director | Other(J) | 2.5M | — | — |
| Nov 18, 2025 | Toi M, LLC | Director | Other(J) | 591K | — | — |
| Nov 18, 2025 | Toi M, LLC | Director | Other(J) | 12K | — | — |
| Nov 18, 2025 | Ling Gabriel | Director | Other(J) | 141K | — | — |
| Nov 17, 2025 | Carter Robert Ross | Chief Financial Officer | Grant(A) | 195 | — | $0 |
| Nov 17, 2025 | Podnos Yale | Chief Medical Officer | Grant(A) | 2K | — | $0 |
| Nov 17, 2025 | Virnich Daniel | Chief Executive Officer | Grant(A) | 6K | — | $0 |
| Nov 12, 2025 | Podnos Yale | Chief Medical Officer | Grant(A) | 306 | — | $0 |
| Nov 12, 2025 | Podnos Yale | Chief Medical Officer | Grant(A) | 1K | — | $0 |
| Nov 12, 2025 | Virnich Daniel | Chief Executive Officer | Grant(A) | 6K | — | $0 |
| Sep 4, 2025 | M33 Growth I GP LLC | Director, 10% Owner | Sell(S) | 682K | $3.09 | $2.1M |
| Sep 4, 2025 | M33 Growth I GP LLC | Director, 10% Owner | Sell(S) | 6.0M | $3.09 | $18.6M |
| Aug 19, 2025 | Hively Brad | Director | Sell(S) | 20K | $4.06 | $82K |
| Jul 24, 2025 | Barasch Richard A | Director | Other(J) | 288K | — | $0 |
| Jul 22, 2025 | England Kristin | Chief Administrative Officer | Grant(A) | 98K | — | $0 |
| Jun 18, 2025 | Barasch Richard A | Director | Conversion(C) | 620K | — | $0 |
| Jun 18, 2025 | Barasch Richard A | Director | Conversion(C) | 6K | — | $0 |
| Jun 17, 2025 | Barasch Richard A | Director | Tax withholding(F) | 311K | $2.62 | $815K |
| Jun 17, 2025 | Barasch Richard A | Director | Option exercise(X) | 679K | $1.20 | $815K |
| Jun 17, 2025 | Barasch Richard A | Director | Option exercise(X) | 679K | — | $0 |
| Jun 17, 2025 | Barasch Richard A | Director | Conversion(C) | 160K | — | $0 |
| Jun 17, 2025 | Barasch Richard A | Director | Conversion(C) | 2K | — | $0 |
| Jun 5, 2025 | M33 Growth I GP LLC | Director, 10% Owner | Sell(S) | 674K | $3.05 | $2.1M |
| Jun 5, 2025 | M33 Growth I GP LLC | Director, 10% Owner | Sell(S) | 76K | $3.05 | $233K |
| Jun 3, 2025 | Hively Brad | Director | Sell(S) | 109K | $2.87 | $311K |
| Jun 3, 2025 | Hively Brad | Director | Sell(S) | 1.9M | $2.87 | $5.4M |
| Jun 3, 2025 | Hively Brad | Director | Option exercise(M) | 946K | $0.85 | $804K |
| Jun 3, 2025 | Hively Brad | Director | Option exercise(M) | 131K | $1.87 | $246K |
| Jun 3, 2025 | Hively Brad | Director | Option exercise(M) | 105K | $0.48 | $51K |
| Jun 3, 2025 | Hively Brad | Director | Option exercise(M) | 685K | $0.85 | $582K |
| Jun 3, 2025 | Hively Brad | Director | Option exercise(M) | 946K | — | $0 |
| Jun 3, 2025 | Hively Brad | Director | Option exercise(M) | 131K | — | $0 |
| Jun 3, 2025 | Hively Brad | Director | Option exercise(M) | 105K | — | $0 |
| Jun 3, 2025 | Hively Brad | Director | Option exercise(M) | 685K | — | $0 |
| May 21, 2025 | Langsam Jeffrey | Chief Clinical Officer | Grant(A) | 57K | — | $0 |
| May 21, 2025 | Castle Jeremy | Chief Operating Officer | Disposed to issuer(D) | 6K | $2.68 | $15K |
| May 21, 2025 | Carter Robert Ross | Chief Financial Officer | Disposed to issuer(D) | 2K | $2.68 | $4K |
| May 21, 2025 | Podnos Yale | Chief Medical Officer | Disposed to issuer(D) | 2K | $2.68 | $5K |
| May 21, 2025 | Virnich Daniel | Chief Executive Officer | Disposed to issuer(D) | 20K | $2.68 | $55K |
| May 20, 2025 | M33 Growth I GP LLC | Director, 10% Owner | Sell(S) | 1.8M | $2.71 | $4.9M |
| May 20, 2025 | M33 Growth I GP LLC | Director, 10% Owner | Sell(S) | 204K | $2.71 | $552K |
| Mar 31, 2025 | Virnich Daniel | Chief Executive Officer | Grant(A) | 1.1M | — | $0 |
| Mar 31, 2025 | Castle Jeremy | Chief Operating Officer | Grant(A) | 162K | — | $0 |
| Mar 31, 2025 | Carter Robert Ross | Chief Financial Officer | Grant(A) | 197K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).